Corbin Capital Partners’s Tevogen Bio Holdings TVGN Stock Holding History

Corbin Capital Partners’s Portfolio TVGN Stock Details TVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-46,400	Closed	-$24.5M	–	57
2023 Q2	$24.5M	Hold	46,400	–	–	20.66%	1
2023 Q1	$25M	Hold	46,400	–	–	13.9%	2
2022 Q4	$24M	Hold	46,400	–	–	7.29%	2
2022 Q3	$23.5M	Hold	46,400	–	–	5.85%	2
2022 Q2	$23.2M	Hold	46,400	–	–	5.26%	2
2022 Q1	$23.2M	Buy	+46,400	New	+$23.1M	3.96%	5

Other funds holding TVGN

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

WRBC

W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return

CCA

Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

RCM

Robinson Capital Management Grosse Pointe Farms, Michigan $239M AUM 0.62% 1-Year Est. Return

Corbin Capital Partners's TVGN Position: Q3 2023 in Review

Corbin Capital Partners sold out of Tevogen Bio Holdings (TVGN) in Q3 2023, closing a stake of 46,400 shares — an estimated $24.5M sold.

Corbin Capital Partners first reported a position in TVGN in Q1 2022 and held it in 6 quarters. The position peaked at $25M in Q1 2023. 13 funds tracked by Wall St. Rank hold TVGN as of Q3 2023.

Corbin Capital Partners reported no remaining Tevogen Bio Holdings position as of Q3 2023 after selling out during the quarter.
Corbin Capital Partners sold 46,400 Tevogen Bio Holdings shares in Q3 2023, an estimated $24.5M.
Corbin Capital Partners first reported a position in Tevogen Bio Holdings in Q1 2022 and held it in 6 quarters.
Corbin Capital Partners's Tevogen Bio Holdings position peaked at $25M in Q1 2023.
13 funds tracked by Wall St. Rank held Tevogen Bio Holdings as of Q3 2023.

Based on Corbin Capital Partners's 13F filing for Q3 2023, filed 14 Nov 2023.